AlphaCrest Capital Management’s Usana Health Sciences USNA Stock Holding History

AlphaCrest Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,823	Closed	-$289K	–	1390
2021 Q2	$289K	Buy	+2,823	New	+$283K	0.01%	1119
2021 Q1	–	Sell	-3,226	Closed	-$249K	–	1313
2020 Q4	$249K	Sell	3,226 -311	-9%	-$24.1K	0.02%	991
2020 Q3	$261K	Buy	+3,537	New	+$284K	0.03%	935
2019 Q4	–	Sell	-7,400	Closed	-$506K	–	1391
2019 Q3	$506K	Buy	+7,400	New	+$497K	0.03%	903
2019 Q1	–	Sell	-3,100	Closed	-$365K	–	963
2018 Q4	$365K	Buy	+3,100	New	+$358K	0.11%	366

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AlphaCrest Capital Management's USNA Position: Q3 2021 in Review

AlphaCrest Capital Management sold out of Usana Health Sciences (USNA) in Q3 2021, closing a stake of 2,823 shares — an estimated $289K sold.

AlphaCrest Capital Management first reported a position in USNA in Q4 2018 and held it in 5 quarters. The position peaked at $506K in Q3 2019. 180 funds tracked by Wall St. Rank hold USNA as of Q3 2021.

AlphaCrest Capital Management reported no remaining Usana Health Sciences position as of Q3 2021 after selling out during the quarter.
AlphaCrest Capital Management sold 2,823 Usana Health Sciences shares in Q3 2021, an estimated $289K.
AlphaCrest Capital Management first reported a position in Usana Health Sciences in Q4 2018 and held it in 5 quarters.
AlphaCrest Capital Management's Usana Health Sciences position peaked at $506K in Q3 2019.
180 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2021.

Based on AlphaCrest Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.